other

Updated:

Dentsply Sirona

Simon Campion leads Dentsply Sirona, a publicly traded dental technology firm with a 130-year history and annual R&D spending near 4% of revenue.

Dentsply Sirona

Simon Campion is President and CEO of Dentsply Sirona, reporting to Executive Chairman Eric K. Brandt. The company was formed through the 2016 merger of Dentsply International and Sirona Dental Systems, combining a century-old dental consumables maker with a digital equipment manufacturer. Its corporate headquarters is in New York, though its operational footprint spans North America, Europe, and Latin America. The firm allocates significant resources to R&D — roughly 4% of revenue annually — and employs over 650 scientists and engineers. Its portfolio covers endodontics, implant dentistry, orthodontics, restorative materials, and digital tools like intraoral scanners (Primescan), 3D printers, milling machines, and CEREC chairside manufacturing. Dentsply Sirona also produces infection control equipment and anesthetics. Notable brands include Astra Tech Implants, WaveOne Gold endodontic files, SureSmile clear aligners, and Cavitron ultrasonic scalers. Dentsply Sirona operates sales and service teams in the US, Canada, Mexico, Brazil, Costa Rica, and Great Britain, with over 4,000 customer service representatives globally. The company hosts annual events like Dentsply Sirona World and the Implant Solutions World Summit. It also sponsors the Foundation for Endodontics Freedom Scholarship, committing $750,000 over five years to support residents. As a publicly traded corporation (NASDAQ: XRAY), Dentsply Sirona is not a family office or asset manager. Its ownership is held by public shareholders, and its investment posture is defined by organic R&D and strategic acquisitions rather than a managed investment pool. The firm reports financials quarterly to the SEC, with transparency standards set by public company regulation.

General information

Firm type

other

Year founded

AUM

Undisclosed

Location

Region

North America

Country

United States

City

New York

Corporate office

New York, United States

Principals

Eric K. Brandt

Executive Chairman

Simon Campion

President and Chief Executive Officer

Sector focus

Digital HealthMedTechHealthcare Services

Frequently asked questions

Who runs investment decisions at Dentsply Sirona?

Simon Campion is President and CEO, responsible for corporate strategy and capital allocation. He reports to the Board of Directors, chaired by Eric K. Brandt. As a public company, major investment decisions require board approval and are disclosed in SEC filings.

Is Dentsply Sirona structured as a family office or investment firm?

No. Dentsply Sirona is a publicly traded dental technology manufacturer (NASDAQ: XRAY). It does not operate as a family office, asset manager, or investment vehicle. Its capital is deployed on R&D, acquisitions, and operations, not external asset management.

How does Dentsply Sirona source new products and technology?

The firm invests roughly 4% of revenue annually in R&D, supported by over 650 scientists and engineers (per firm website, 2026). It also acquires complementary businesses and technologies, though specific deal terms are disclosed in regulatory filings.

What investment stages does Dentsply Sirona typically target?

Dentsply Sirona does not function as an investment firm. Its R&D spend supports internal development of dental products across all stages, from concept to commercialization. Strategic acquisitions are typically of established dental technology businesses.

Which sectors does Dentsply Sirona explicitly focus on?

The firm focuses exclusively on dentistry. Its major segments include endodontics, implant dentistry, orthodontics, restorative materials, digital dentistry (scanners, mills, 3D printing), infection control, and preventive care.

Does Dentsply Sirona participate in fund commitments or only direct deals?

Dentsply Sirona does not invest in external funds. It allocates capital to internal R&D and direct acquisitions of dental technology companies, consistent with its public company mandate.

Where does the underlying wealth for Dentsply Sirona come from?

Dentsply Sirona is a publicly traded company. Its capital comes from revenue generated by product sales and from equity and debt markets. No single family or individual controls the firm.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on family offices?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo